TVM Capital Life Science is a dedicated provider of venture capital to the international pharmaceutical, medical technology and healthcare diagnostics industries.
We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 120 life science companies in Europe and the United States, currently managing in excess of €900 million from more than 50 investors.
TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.